BioSpace News Archive

As the COVID-19 pandemic continues to isolate people around the world, accelerating and intensifying the addiction epidemic and reversing the recovery gains made in 2018, HMP Global, a leading healthcare event and education company, today announced it has entered into a definitive agreement to acquire a portfolio of addiction education meetings from C4 Recovery Foundation

The 73rd Annual Scientific Meeting of the American Academy of Forensic Sciences (AAFS) will take place Feb. 15-19, 2021, virtually hosted by VFairs Virtual Events Software

Spectrum Dynamics Medical, a global leader, developer, manufacturer and seller of digital SPECT imaging equipment, announced that its lawsuit against GE for trade secret misappropriation in the Southern District of New York, Case No. 18-cv-11386 (VSB) is progressing.

Incyte (Nasdaq:INCY) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the conditional marketing authorization of pemigatinib for the treatment of adults with unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2

Stericycle, Inc. today announced it has entered into a settlement agreement with the United States Environmental Protection Agency (EPA) to settle a civil investigation into alleged air emission exceedances at its North Salt Lake, Utah, incineration facility that occurred more than seven years ago between September 2012 and May 2013.

T2 Biosystems, Inc., a global leader in the rapid detection of sepsis-causing pathogens, announced that it issued an inducement award to Dr. Aparna Ahuja, the Company’s recently appointed Chief Medical Officer, in accordance with the terms of Dr. Ahuja’s employment offer letter.

Catalyst Biosciences, Inc. announced the closing of an underwritten public offering of 8,700,000 shares of its common stock, offered at a price of $5.75 per share to the public.

Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced that it will be presenting at the LSX World Congress to be held virtually between February 1-5, 2021.

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select products sold in Latin America to Hypera S.A. (“Hypera Pharma”) for a total value of $825 million USD.

Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has commenced an underwritten public offering of shares of its common stock.